GYNECOLOGICAL MONITORING DURING TAMOXIFEN THERAPY

被引：43

作者：

BISSETT, D ^{[1
]}

DAVIS, JA ^{[1
]}

GEORGE, WD ^{[1
]}

机构：

[1] STOBHILL GEN HOSP,GLASGOW G21 3UW,LANARK,SCOTLAND

来源：

关键词：

D O I：

10.1016/S0140-6736(94)90747-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1244 / 1244

页数：1

共 5 条

[1] CRAWFORD DJ, 1992, BREAST, V1, P35
[2] ENDOMETRIAL CANCER IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP) B-14
FISHER, B
COSTANTINO, JP
REDMOND, CK
FISHER, ER
WICKERHAM, DL
CRONIN, WM
BOWMAN, D
COUTURE, J
DIMITROV, NV
EVANS, J
FARRAR, W
KAVANAH, M
LICKLEY, HL
MARGOLESE, R
PATERSON, AHG
ROBIDOUX, A
SHIBATA, H
TERZ, J
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (07): : 527 - 537
[3] FORNANDER T, 1989, LANCET, V1, P117
[4] EFFECTS OF TAMOXIFEN ON UTERUS AND OVARIES OF POSTMENOPAUSAL WOMEN IN A RANDOMIZED BREAST-CANCER PREVENTION TRIAL
KEDAR, RP
BOURNE, TH
POWLES, TJ
COLLINS, WP
ASHLEY, SE
COSGROVE, DO
CAMPBELL, S
[J]. LANCET, 1994, 343 (8909) : 1318 - 1321
[5] THE CASE FOR CLINICAL-TRIALS OF TAMOXIFEN FOR PREVENTION OF BREAST-CANCER
POWLES, TJ
[J]. LANCET, 1992, 340 (8828) : 1145 - 1147